In noncancerous cells, during viral infection, RSAD2 is upregulated and induced mainly by interferon signaling pathways which enhance the activity of T-cells and alter metabolic processes that attack the virus (9, 10). This evidence concerns the gene RSAD2 and viral infectious disease.